The modified Hodge test is a useful tool for ruling out Klebsiella pneumoniae carbapenemase.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3521806)

Published in Clinics (Sao Paulo) on December 01, 2012

Authors

Ana Paula Cury1, Denise Andreazzi, Márcia Maffucci, Hélio Hehl Caiaffa-Junior, Flávia Rossi

Author Affiliations

1: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Pathology Department, Microbiology Laboratory, São Paulo/SP, Brazil. anapaulacury@gmail.com

Articles cited by this

Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother (2005) 5.70

First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother (2006) 4.66

Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis (2012) 4.62

Statistical methods in microbiology. Clin Microbiol Rev (1990) 4.60

Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother (2006) 4.50

Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother (2005) 4.15

Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother (2006) 3.68

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis (2006) 3.21

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect (2011) 2.92

Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol (2011) 2.65

Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother (2009) 2.56

Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother (2011) 2.42

Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapenemase in species of enterobacteriaceae by incorporating boronic Acid. J Clin Microbiol (2010) 1.97

First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother (2008) 1.93

Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect (2009) 1.76

Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J Clin Microbiol (2010) 1.57

Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae. Microb Drug Resist (2010) 1.33

Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb Drug Resist (2007) 1.27

Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest. J Clin Microbiol (2011) 1.20

Early dissemination of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother (2009) 1.07

Articles by these authors

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother (2005) 1.55

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother (2007) 1.20

16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil. J Antimicrob Chemother (2008) 1.12

Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex. Braz J Infect Dis (2011) 1.07

In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) (2009) 1.04

Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) (2010) 1.04

Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol (2008) 0.88

Carbapenem stewardship: positive impact on hospital ecology. Braz J Infect Dis (2011) 0.87

Brazilian guidelines for community-acquired pneumonia in immunocompetent adults - 2009. J Bras Pneumol (2009) 0.87

In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect (Larchmt) (2006) 0.86

Candida haemulonii Complex Species, Brazil, January 2010-March 2015. Emerg Infect Dis (2016) 0.86

Overview of tigecycline and its role in the era of antibiotic resistance. Braz J Infect Dis (2006) 0.84

Increasing prevalence of extended-spectrum-beta-lactamase among Gram-negative bacilli in Latin America--2008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Braz J Infect Dis (2011) 0.82

First report of a clinical isolate of Candida haemulonii in Brazil. Clinics (Sao Paulo) (2012) 0.79

Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin. J Bras Pneumol (2012) 0.77

Smqnr variants in clinical isolates of Stenotrophomonas maltophilia in Brazil. Rev Inst Med Trop Sao Paulo (2013) 0.75

Interactive tele-education applied to a distant clinical microbiology specialization university course. Telemed J E Health (2011) 0.75